199 related articles for article (PubMed ID: 20556477)
21. Human immunodeficiency virus-associated lymphomas in the antiretroviral therapy era: Analysis of the National Cancer Data Base.
Olszewski AJ; Fallah J; Castillo JJ
Cancer; 2016 Sep; 122(17):2689-97. PubMed ID: 27337679
[TBL] [Abstract][Full Text] [Related]
22. Radiotherapy of primary central nervous system lymphoma in patients with and without human immunodeficiency virus. Ten years of treatment experience at the University of California San Francisco.
Ling SM; Roach M; Larson DA; Wara WM
Cancer; 1994 May; 73(10):2570-82. PubMed ID: 8174055
[TBL] [Abstract][Full Text] [Related]
23. Incidence and outcomes of primary central nervous system lymphoma in solid organ transplant recipients.
Mahale P; Shiels MS; Lynch CF; Engels EA
Am J Transplant; 2018 Feb; 18(2):453-461. PubMed ID: 28805292
[TBL] [Abstract][Full Text] [Related]
24. Natural history and prognostic factors for survival in patients with acquired immune deficiency syndrome (AIDS)-related primary central nervous system lymphoma (PCNSL).
Raez LE; Patel P; Feun L; Restrepo A; Raub WA; Cassileth PA
Crit Rev Oncog; 1998; 9(3-4):199-208. PubMed ID: 10201628
[TBL] [Abstract][Full Text] [Related]
25. Primary central nervous system lymphoma in Japan--a retrospective, co-operative study by CNS-Lymphoma Study Group in Japan.
Hayakawa T; Takakura K; Abe H; Yoshimoto T; Tanaka R; Sugita K; Kikuchi H; Uozumi T; Hori T; Fukui H
J Neurooncol; 1994; 19(3):197-215. PubMed ID: 7807171
[TBL] [Abstract][Full Text] [Related]
26. Role of chemotherapy additional to high-dose methotrexate for primary central nervous system lymphoma (PCNSL).
Bergner N; Monsef I; Illerhaus G; Engert A; Skoetz N
Cochrane Database Syst Rev; 2012 Nov; 11():CD009355. PubMed ID: 23152274
[TBL] [Abstract][Full Text] [Related]
27. Primary central nervous system lymphoma in immunocompetent individuals: a single center experience.
Aki H; Uzunaslan D; Saygin C; Batur S; Tuzuner N; Kafadar A; Ongoren S; Oz B
Int J Clin Exp Pathol; 2013; 6(6):1068-75. PubMed ID: 23696924
[TBL] [Abstract][Full Text] [Related]
28. Long term outcomes in older patients with primary central nervous system lymphoma: an analysis of the Texas Cancer Registry.
Burns EA; Sanchez CG; Mathur S; Guerrero C; Muhsen IN; Sarfraz H; Hu CA; Tang CA; Shah SS; Tremont IW; Teh B; Ganguly S; Pingali SRK
Ann Hematol; 2023 May; 102(5):1111-1120. PubMed ID: 36922432
[TBL] [Abstract][Full Text] [Related]
29. Clinicopathological features, survival and prognostic factors of primary central nervous system lymphomas: trends in incidence of primary central nervous system lymphomas and primary malignant brain tumors in a well-defined geographical area. Population-based data from the Danish Lymphoma Registry, LYFO, and the Danish Cancer Registry.
Krogh-Jensen M; D'Amore F; Jensen MK; Christensen BE; Thorling K; Pedersen M; Johansen P; Boesen AM; Andersen E
Leuk Lymphoma; 1995 Oct; 19(3-4):223-33. PubMed ID: 8535213
[TBL] [Abstract][Full Text] [Related]
30. Non-Hodgkin's lymphoma among patients infected with human immunodeficiency virus: the experience of a single center in Brazil.
Tanaka PY; Pracchia LF; Calore EE
Int J Hematol; 2006 Nov; 84(4):337-42. PubMed ID: 17118760
[TBL] [Abstract][Full Text] [Related]
31. A prognostic index for systemic AIDS-related non-Hodgkin lymphoma treated in the era of highly active antiretroviral therapy.
Bower M; Gazzard B; Mandalia S; Newsom-Davis T; Thirlwell C; Dhillon T; Young AM; Powles T; Gaya A; Nelson M; Stebbing J
Ann Intern Med; 2005 Aug; 143(4):265-73. PubMed ID: 16103470
[TBL] [Abstract][Full Text] [Related]
32. Whole brain radiotherapy improves survival outcomes in primary CNS lymphoma patients ineligible for systemic therapy.
Song J; Samant R; Jay M; Chaudry H; Fan XY; MacDonald D; Bence-Bruckler I; Nair V
Support Care Cancer; 2020 Nov; 28(11):5363-5369. PubMed ID: 32140974
[TBL] [Abstract][Full Text] [Related]
33. Human immunodeficiency virus-related primary central nervous system lymphoma: factors influencing survival in 111 patients.
Newell ME; Hoy JF; Cooper SG; DeGraaff B; Grulich AE; Bryant M; Millar JL; Brew BJ; Quinn DI
Cancer; 2004 Jun; 100(12):2627-36. PubMed ID: 15197806
[TBL] [Abstract][Full Text] [Related]
34. Results of combined-modality therapy for primary and secondary malignant lymphoma of the central nervous system (CNS).
Kawamura T; Koga S; Okamoto M; Kanno T; Iwamura H
Radiat Med; 2001; 19(3):145-9. PubMed ID: 11467381
[TBL] [Abstract][Full Text] [Related]
35. Treatment and prognosis of AIDS-related lymphoma in the era of highly active antiretroviral therapy: findings from the Swiss HIV Cohort Study.
Simcock M; Blasko M; Karrer U; Bertisch B; Pless M; Blumer L; Vora S; Robinson JO; Bernasconi E; Terziroli B; Moirandat-Rytz S; Furrer H; Hirschel B; Vernazza P; Sendi P; Rickenbach M; Bucher HC; Battegay M; Koller MT;
Antivir Ther; 2007; 12(6):931-9. PubMed ID: 17926647
[TBL] [Abstract][Full Text] [Related]
36. Primary central nervous system lymphoma. Results at the University of California at Los Angeles and review of the literature.
Selch MT; Shimizu KT; De Salles AF; Sutton C; Parker RG
Am J Clin Oncol; 1994 Aug; 17(4):286-93. PubMed ID: 8048389
[TBL] [Abstract][Full Text] [Related]
37. Characteristics and outcomes of elderly patients with primary central nervous system lymphoma: the Memorial Sloan-Kettering Cancer Center experience.
Ney DE; Reiner AS; Panageas KS; Brown HS; DeAngelis LM; Abrey LE
Cancer; 2010 Oct; 116(19):4605-12. PubMed ID: 20572045
[TBL] [Abstract][Full Text] [Related]
38. Changing incidence and survival in patients with aids-related non-Hodgkin's lymphomas in the era of highly active antiretroviral therapy (HAART).
Chow KU; Mitrou PS; Geduldig K; Helm EB; Hoelzer D; Brodt HR
Leuk Lymphoma; 2001 Mar; 41(1-2):105-16. PubMed ID: 11342362
[TBL] [Abstract][Full Text] [Related]
39. [Clinical features and treatment outcomes in primary central nervous system lymphoma: a descriptive analysis of 62 patients].
Ge Y; Lin XT; Luo DL; Zhang F; Xu J; Li Z; Liu YH
Zhonghua Bing Li Xue Za Zhi; 2019 Nov; 48(11):861-866. PubMed ID: 31775435
[No Abstract] [Full Text] [Related]
40. Risk Factors for Early Mortality in Patients with Primary Central Nervous System Lymphoma: A Large-Cohort Retrospective Study.
Zhou X; Niu X; Li J; Zhang S; Yang W; Yang Y; Mao Q; Liu Y
World Neurosurg; 2020 Jun; 138():e905-e912. PubMed ID: 32251807
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]